novartis ceo: growth drivers performing well, but product exclusivity losses creating headwinds
Published 6 months ago • 5.1K plays • Length 9:48Download video MP4
Download video MP3
Similar videos
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
4:54
novartis ceo: confident about continued sales growth for rest of year
-
6:12
novartis ceo: expect continued growth in 2023
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
3:29
innovative medicines business returning to growth, novartis ceo says
-
5:20
'attractive' growth ahead for novo nordisk, ceo says
-
43:50
vasant narasimhan, chief executive officer, novartis | bsr18
-
4:27
vas narasimhan and author dan pink talk culture and leadership
-
23:37
reimagining medicine with data & digital | novartis ceo at #vivatech19
-
1:51
committed to growing over 4% through 2026, says novartis ceo
-
3:04
novartis ceo: spinoffs will see us succeed as a pure-play innovative medicines company
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
26:06
looking for a better owner for our india-listed biz: novartis ceo | exclusive | global dialogues
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
5:31
novartis' ceo sees very strong pipeline for future
-
4:22
novartis ceo on new cancer therapy programs
-
3:34
expect concrete decision before the end of the year on sandoz, says novartis ceo
-
14:53
took a hard decision to focus on 4 therapeutic areas: novartis ceo | exclusive | cnbc tv18
-
0:45
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
-
4:37
software firm discusses ai adoption and regulation
-
2:25
nvidia's august earnings report unlikely to have any 'major issue': research firm